Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
LanZhou Foci Pharmaceutical (002644)
- 8.43
- -0.22-2.54%
Market Closed Apr 17 15:00 CST
4.30BMarket Cap87.81P/E (TTM)
8.66High8.38Low65.34KlotVolume8.66Open8.65Prev Close55.46MTurnover1.28%Turnover Ratio87.81P/E (Static)510.66MShares11.8552wk High2.35P/B4.30BFloat Cap7.5452wk Low9.52Limit Up510.66MShs Float26.87Historical High7.79Limit Down3.24%Range %2.14Historical Low0.01Dividend TTM8.49Avg Price43.27KlotAsk0.14%Div Yield TTM100Lot Size20.37KlotBid
LanZhou Foci Pharmaceutical (002644) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.60%915.53M | -11.92%624.06M | -13.93%429.37M | -21.22%216.12M | -15.73%980.23M | -19.75%708.53M | -20.26%498.88M | -13.85%274.33M | 11.58%1.16B | 26.42%882.92M |
| Operating revenue | -6.60%915.53M | -11.92%624.06M | -13.93%429.37M | -21.22%216.12M | -15.73%980.23M | -19.75%708.53M | -20.26%498.88M | -13.85%274.33M | 11.58%1.16B | 26.42%882.92M |
| Other operating revenue | -7.71%2.57M | ---- | -56.18%759.21K | ---- | -48.98%2.78M | ---- | 34.60%1.73M | ---- | 244.39%5.45M | ---- |
| Total operating cost | -9.95%813.85M | -13.39%564.31M | -15.34%380.74M | -22.80%189.74M | -16.26%903.74M | -20.99%651.59M | -20.96%449.71M | -15.81%245.79M | 13.57%1.08B | 27.28%824.71M |
| Operating cost | -11.33%603.42M | -13.08%418.62M | -15.21%283.95M | -24.86%142.04M | -15.13%680.51M | -22.45%481.63M | -21.47%334.87M | -17.83%189.02M | 8.77%801.84M | 24.56%621.04M |
| Operating tax surcharges | 10.46%15.57M | 8.56%10.85M | 11.17%7.3M | 10.53%3.95M | 5.50%14.1M | 5.65%10M | 1.43%6.56M | 29.16%3.57M | -8.24%13.36M | 2.01%9.46M |
| Operating expense | -11.79%102.36M | -22.39%72.22M | -23.95%46.9M | -27.69%20.23M | -24.51%116.04M | -19.42%93.06M | -25.43%61.68M | -13.29%27.98M | 33.79%153.73M | 35.77%115.48M |
| Administration expense | 5.65%72.86M | -4.75%47.15M | -8.38%31.73M | -12.92%16.35M | -18.19%68.96M | -19.79%49.5M | -15.72%34.63M | -13.36%18.77M | 24.64%84.29M | 34.14%61.71M |
| Financial expense | 4.79%-4.91M | 40.20%-2.61M | 8.97%-2.41M | -26.46%-565.14K | -3.56%-5.15M | -2.58%-4.36M | -0.34%-2.65M | 58.87%-446.91K | 34.72%-4.97M | 20.17%-4.25M |
| -Interest expense (Financial expense) | -7.30%770.72K | 72.72%1.68M | -8.91%378.45K | ---- | -32.99%831.44K | -41.67%973.58K | -41.45%415.45K | ---- | -8.10%1.24M | --1.67M |
| -Interest Income (Financial expense) | -2.69%-5.9M | 21.27%-4.29M | 8.74%-2.83M | ---- | -6.97%-5.74M | -4.47%-5.45M | 12.26%-3.1M | ---- | 28.55%-5.37M | ---5.21M |
| Research and development | -16.15%24.56M | -16.97%18.07M | -9.17%13.28M | 12.44%7.74M | -5.31%29.28M | 2.36%21.77M | -1.93%14.62M | 9.37%6.89M | 31.29%30.93M | 48.27%21.27M |
| Credit Impairment Loss | -68.26%-56.65M | -36.56%-28.86M | -55.55%-21.48M | -0.34%-8.02M | -129.99%-33.67M | -724.10%-21.14M | -497.19%-13.81M | -345.87%-8M | 37.23%-14.64M | 110.93%3.39M |
| Asset Impairment Loss | -1,081.99%-1.79M | ---- | ---- | ---- | 85.65%-151.74K | -108.02%-17.69K | -107.79%-17.69K | ---- | -737.48%-1.06M | --220.64K |
| Other net revenue | -491.36%-35.7M | -52.09%-16.16M | -102.67%-14.02M | 37.41%-3.47M | -776.07%-6.04M | -156.61%-10.63M | -147.48%-6.92M | -251.82%-5.54M | -101.35%-689.03K | 20.24%18.77M |
| Invest income | -87.16%-13.54M | 13.91%-5.61M | -14.95%-3.92M | 61.08%-1.02M | -61.04%-7.23M | -646.73%-6.52M | -333.26%-3.41M | -525.78%-2.61M | -246.29%-4.49M | 134.85%1.19M |
| -Including: Investment income associates | -60.19%-13.52M | 14.38%-5.61M | ---- | 61.08%-1.02M | -84.90%-8.44M | -648.87%-6.56M | ---- | -525.78%-2.61M | -14.14%-4.56M | --1.19M |
| Asset deal income | 17,535.87%7.13M | -87.88%1.42K | -87.88%1.42K | 705.83%1.42K | --40.44K | --11.68K | --11.68K | --175.71 | ---- | ---- |
| Other revenue | -16.66%29.15M | 7.49%18.31M | 10.40%11.38M | 10.01%5.57M | 79.37%34.97M | 21.98%17.04M | 9.71%10.31M | 0.04%5.06M | -74.24%19.5M | -19.84%13.97M |
| Operating profit | -6.33%65.99M | -5.91%43.58M | -18.11%34.61M | -0.38%22.91M | -15.41%70.45M | -39.83%46.32M | -40.71%42.26M | -23.72%23M | -41.82%83.27M | 16.52%76.98M |
| Add:Non operating Income | 90.54%830K | 1,202.37%429.25K | 30,097.19%1.32M | 21,093.15%894.83K | 274.17%435.6K | -49.05%32.96K | -92.48%4.38K | -89.68%4.22K | -36.83%116.42K | -76.42%64.69K |
| Less:Non operating expense | 2.48%1.79M | 155.42%1.74M | 173.93%1.29M | -81.63%73.63K | -0.44%1.74M | -33.33%679.81K | -53.50%470.84K | 595.80%400.83K | -86.13%1.75M | -80.05%1.02M |
| Total profit | -5.94%65.03M | -7.44%42.28M | -17.12%34.64M | 5.00%23.73M | -15.31%69.14M | -39.92%45.67M | -40.57%41.79M | -25.00%22.6M | -37.54%81.64M | 24.17%76.02M |
| Less:Income tax cost | 141.85%18.08M | -1.76%5.13M | -0.75%4.69M | -8.90%3.61M | -44.72%7.47M | -66.03%5.22M | -61.51%4.73M | -36.43%3.96M | -36.73%13.52M | 91.49%15.37M |
| Net profit | -23.86%46.96M | -8.17%37.14M | -19.20%29.95M | 7.95%20.12M | -9.48%61.67M | -33.30%40.45M | -36.13%37.06M | -22.01%18.64M | -37.70%68.12M | 14.01%60.65M |
| Net profit from continuing operation | -23.86%46.96M | -8.17%37.14M | -19.20%29.95M | 7.95%20.12M | -9.48%61.67M | -33.30%40.45M | -36.13%37.06M | -22.01%18.64M | -37.70%68.12M | 14.01%60.65M |
| Less:Minority Profit | -241.13%-2.25M | -168.15%-937.61K | -116.33%-158.18K | 191.96%742.59K | 71.17%1.6M | 145.73%1.38M | 264.38%968.58K | 2,360.15%254.35K | 34.40%932.29K | 77.02%559.86K |
| Net profit of parent company owners | -18.08%49.21M | -2.54%38.08M | -16.60%30.1M | 5.41%19.38M | -10.60%60.07M | -34.97%39.07M | -37.52%36.1M | -23.11%18.39M | -38.16%67.19M | 13.63%60.09M |
| Earning per share | ||||||||||
| Basic earning per share | -18.03%0.0964 | -2.48%0.0746 | -16.55%0.059 | 5.56%0.038 | -10.64%0.1176 | -35.00%0.0765 | -37.49%0.0707 | -23.08%0.036 | -38.16%0.1316 | 13.72%0.1177 |
| Diluted earning per share | -18.03%0.0964 | -2.48%0.0746 | -16.55%0.059 | 5.56%0.038 | -10.64%0.1176 | -35.00%0.0765 | -37.49%0.0707 | -23.08%0.036 | -38.16%0.1316 | 13.72%0.1177 |
| Other composite income | -168.85%-90.16K | -91.07%43.58K | -91.22%43.58K | 154.12%130.95K | 1,166.78%487.79K | 938.09%496.37K | -191.29%-241.98K | -20.04%38.51K | ||
| Other composite income of parent company owners | -167.94%-46.49K | -91.07%22.47K | -91.22%22.47K | ---- | 151.71%68.43K | 1,094.39%251.52K | 878.77%255.94K | ---- | -191.29%-132.33K | -16.67%21.06K |
| Other composite income of minority owners | -169.85%-43.67K | -91.07%21.11K | -91.22%21.11K | ---- | 157.02%62.52K | 1,254.14%236.28K | 1,009.68%240.43K | ---- | -191.29%-109.65K | -23.77%17.45K |
| Total composite income | -24.16%46.86M | -9.16%37.19M | -20.15%29.99M | 7.95%20.12M | -8.96%61.8M | -32.54%40.94M | -35.33%37.56M | -22.01%18.64M | -38.07%67.88M | 13.98%60.68M |
| Total composite income of parent company owners | -18.25%49.16M | -3.10%38.1M | -17.12%30.13M | 5.41%19.38M | -10.32%60.14M | -34.58%39.32M | -37.10%36.35M | -23.11%18.39M | -38.37%67.06M | 13.62%60.11M |
| Total composite income of minority owners | -238.44%-2.3M | -156.85%-916.5K | -111.34%-137.07K | 191.96%742.59K | 101.58%1.66M | 179.23%1.61M | 320.55%1.21M | 2,360.15%254.35K | 1.09%822.64K | 70.21%577.31K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | LianDa Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm